Development and validation of a stability indicating RP-HPLC method for simultaneous determination of Lamivudine and Stavudine in combined dosage forms

Journal of Chemical and Pharmaceutical Research

Volumn 3, Issue 6, 2011, Pages 200-211

  Patel, Umesh M ^a   Nageswara Rao, R ^b  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Forced degradation; Lamivudine; Method validation; RP HPLC; Stability indicating assay; Stavudine

Indexed keywords

FORCED DEGRADATION; LAMIVUDINE; METHOD VALIDATIONS; RP-HPLC; STABILITY-INDICATING ASSAYS; STAVUDINE;

DEGRADATION; DRUG DOSAGE; SEPARATION; STABILITY; THERMAL CONDUCTIVITY;

DRUG PRODUCTS;

LAMIVUDINE; STAVUDINE;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG HYDROLYSIS; DRUG ISOLATION; DRUG STABILITY; LIMIT OF DETECTION; OXIDATION; PHOTOLYSIS; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TABLET; TEMPERATURE STRESS; ULTRAVIOLET RADIATION; VALIDATION STUDY;

EID: 84858687063     PISSN: None     EISSN: 09757384     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. J. A. Coates, N. Cammack, H. J. Jenkinson, A. J. Jowett, M. I. Jowett, B. A. Pearson, C. R. Penn, P. L. Rouse, K. C. Viner, J. M. Cameron, J Antimicrob Chemother., 36, 733 (1992)
2. J.M. Pluda, T.P. Cooley, J.S. Montaner, L.E. Shay, N.E. Reinhalter, S.N. Warthan, J. Ruedy, H.M. Hirst, C.A. Vicary, J.B. Quinn, J Infect Dis, 171, 1438 (1995)
3. J.L. Dienstag, R.P. Perrillo, E.R. Schiff, M. Bartholomew, C. Vicary, M. Rubin, New Engl. J Med, 333, 1657 (1995)
4. AHFS Drug Information, 2008, pp. 744-746
5. B.A. Larder, S.D. Kemp, P.R. Harrigan, Science, 269, 696 (1995)
6. D.D. Richman, J.M. Grimes, S.W. Lagakos, J acquir immune Defic Syndr., 3, 743 (1990)
7. Guidelines for the Use of Antiretroviral Agents in HIV Infected Adults and Adolescents, US Department Of Health And Human Services, January 10, 2011
8. N. Kaul, H. Agrawal, A. R. Paradkar, K. R. Mahadik, Chromatographia, 60, 213 (2004)
9. G. Bedse, V. Kumar; S. Singh, Journal of Pharmaceutical and Biomedical Analysis, 49, 55 (2009)
10. http://www.whoint/medicines/publications/pharmacopoeia/QAS_124rev2Lamivudine.mono.FINALpdf
11. P. J. Wagh, N. Pai, Indian Drugs, 39, 654 (2002)
12. P. Djurdjevic, A. Laban, S. Markovic, M. Jelikic-Stankov, Anal. Lett. 37, 2649 (2004)
13. G. Bahrami, S. Mirzaeei, A. Kiani, B. Mohammadi, J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 823, 213 (2005)
14. X.J. Zhou, J.P. Sommadossi, Journal of Chrom. B: Biomedical Sciences and Applications, 691, 417 (1997)
15. B. Jayakar. B. M. Kumar, C. Saravanan, M. V. Kumudhavalli, J. Chem. Pharm. Res., 2(1): 478 (2010).
16. J. Nijamdeen, B. Jayalakshmi, N. Senthilkumar, Vijayamirtharaj C. Saravanan, J. Chem. Pharm. Res., 2(3):92 (2010).
17. A. S. Pereira, K. B. Kenney, M. S. Cohen, J. E. Hall, J. J. Eron, R. R. Tidwell, J. A. Dunn, Journal of Chrom. B: Biomedical Sciences and Applications, 742, 173 (2000)
18. Q. Zheng, X. Li, J. Jiang, B. Hu. Yaowu Fenxi Zazhi, 25, 73 (2005).
19. D.K. Mandloi, P.K. Tyagi, V.K. Rai, S. Dey, R.K. Ashada, P. Mohanraj, J. Chem. Pharm. Res., 1(1): 286 (2009).
20. T. Sudha, J. Saminathan, Anusha. Kondapalli, Keerthi. Manthena, Bhargavi. Yanamadala, Ganesan V, J. Chem. Pharm. Res., 2(5): 45 (2010).
21. N. Kaul, H. Agrawal, A.R. Paradkar, K.R. Mahadik, Journal of Chromatographic Science, 43, 406 (2005)
22. A. Dunge, N. Sharda, B. Singh, S. Singh, Journal Of Pharmaceutical and Biomedical Analysis, 37, 1115 (2005)
23. http://www.who.int/medicines/publications/pharmacopoeia/QAS_123rev2_Stavudine_mono_FINAL07.pdf
24. G. Aymard, M. Legrand, N. Trichereau,B. Diquet, Journal of Chrom. B: Biomedical Sciences and Applications, 744, 227 (2000)
25. S. Kaul, K.A. Dandekar, K.A. Pittman, Pharm. Res. 6, 895 (1989)
26. M. Sarasa, N. Riba, L. Zamora, X Carne, Journal of Chrom. B: Biomedical Sciences and Applications, 746, 183 (2000)
27. J.S. Janiszewski, D.E. Mulvana, S. Kaul, K.A. Dandekar, R.H. Barbhaiya, J Chromatogr., 577, 151 (1992)
28. S.L. Wong, R.J. Sawchuk, Pharm. Res. 8, 619 (1991)
29. F. Becher, A. Pruvost, C. Goujard, C. Guerreiro, J.F. Delfraissy, J. Grassi, H. Benech, Rapid Commun. Mass Spectrom. 16, 555 (2002)
30. N. Kapoor, S. Khandavilli, R. Panchagnula, J Pharm. Biomed. Anal., 41,761 (2006)
31. Ch. Balasekar reddy, B. Z. Awen, Ch. B. Rao, N. Sreekanth, P. Ramalingam, an International Journal of Advances in Pharmaceutical Sciences, 1, 22 (2010)
32. P.K. Saini, R.M. Singh, C.L. Jain, S.C. Mathur, G. N. Singh. Journal of Pharmacy Research, 2, 1598 (2009)
33. S. Jayaseelan, S. Ganesh, M. Rajasekar, V. Sekar, P. Perumal, International Journal of Pharm.Tech. Research, 2, 1539 (2010)
34. ICH, Q1A (R2): Stability Testing Of New Drug Substances and Products, International Conference on Harmonization Inter February 2003
35. FDA, Guidance for Industry: Stability Testing Of Drug Substances and Drug Products (Draft Guidance), Food and Drug Administration, Rockville, MD, November 2003
36. CPMP, Note for Guidance on Stability Testing Of Existing Active Substances and Related Finished Products. Committee for Proprietary Medicinal Products, EMEA, London, March 2003
37. ICH, Q1 B: Photostability Testing Of New Drug Substances and Products Q1B, International Conference on Harmonization, November 1996
38. ICH Q2 (R1): Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonisation, November 2005
39. S. Ahuja, S. Scypinski, Handbook of modern pharmaceutical analysis. Academic press, New York, 2001, pp. 415-443
40. M. Bakshi, and S.J. Singh, J Pharm. Biomed. Anal., 28, 1011, (2002)